VolitionRx (VNRX) Earnings Date, Estimates & Call Transcripts → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free VNRX Stock Alerts $0.89 +0.01 (+1.14%) (As of 05/3/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Earnings SummaryLatest Earnings DateMar. 25EstimatedActual EPS (Mar. 25) -$0.11 Missed By -$0.11 Get VolitionRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for VNRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueVNRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.VNRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details VolitionRx Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.50) EPSNext Year EPS Consensus Estimate: ($0.33) EPSVNRX Earnings Date and InformationVolitionRx last released its earnings data on March 25th, 2024. The medical research company reported ($0.11) earnings per share (EPS) for the quarter. The firm had revenue of $0.24 million for the quarter, compared to analysts' expectations of $0.50 million. VolitionRx has generated ($0.56) earnings per share over the last year (($0.56) diluted earnings per share). Earnings for VolitionRx are expected to grow in the coming year, from ($0.50) to ($0.33) per share. Read More VolitionRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/25/2024Q4 2023-($0.11)($0.11)($0.11)$0.50 million$0.24 million11/14/2023Q3 2023($0.12)($0.11)+$0.01($0.11)$0.26 million$0.17 million 8/14/2023Q2 2023($0.13)($0.14)($0.01)($0.14)$0.29 million$0.22 million 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million5/10/2023Q1 2023-($0.15)($0.15)($0.15)-$0.15 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million3/15/2023Q4 2022($0.15)($0.13)+$0.02($0.13)$0.06 million$0.12 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 millionAutomatic Income (from home) (Ad)For over 22 years, Wall Street elites have kept this little-known "income hack" from everyday investors… 6 simple clicks have set up HUGE payouts for "in-the-know" investors… Delivering them passive income 365 days a year. Just click here now to watch my presentation for free.11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million11/14/2022Q3 2022($0.15)($0.14)+$0.01($0.14)$0.05 million$0.03 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million8/10/2022Q2 2022($0.15)($0.14)+$0.01($0.14)$0.12 million$0.04 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million5/11/2022Q1 2022$0.04($0.14)($0.18)($0.14)$10.01 million$0.11 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million3/30/2022Q4 2021-($0.15)($0.15)($0.15)$0.03 million$0.01 million 11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.10)($0.13)($0.03)($0.13)$0.03 million$0.03 million11/10/2021Q3 2021($0.11)($0.13)($0.02)($0.13)$0.03 million$0.03 million 8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million8/11/2021Q2 2021($0.12)($0.10)+$0.02($0.10)$0.05 million$0.03 million 5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1 2021-($0.12)($0.12)($0.12)-$0.03 million5/11/2021Q1($0.1170)($0.12)($0.0030)($0.12)-$0.03 million VolitionRx Earnings - Frequently Asked Questions When did VolitionRx announce their last quarterly earnings? VolitionRx (NYSEAMERICAN:VNRX) last announced its quarterly earning data on Monday, March 25, 2024. Learn more on VNRX's earnings history. How much revenue does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded annual revenue of $310,000.00. How much profit does VolitionRx generate each year? VolitionRx (NYSEAMERICAN:VNRX) has a recorded net income of -$30.27 million. VNRX has generated -$0.56 earnings per share over the last four quarters. What is VolitionRx's EPS forecast for next year? VolitionRx's earnings are expected to grow from ($0.50) per share to ($0.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies: ELDN Earnings Results VASO Earnings Results AVRO Earnings Results FIXX Earnings Results ABIO Earnings Results GANX Earnings Results ZEPP Earnings Results ICCM Earnings Results SRTS Earnings Results RPHM Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NYSEAMERICAN:VNRX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldFW: 234x GainWeiss RatingsThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
